1 | Study | 0.92% | |
2 | Cancer | 0.86% | |
3 | Health | 0.82% | |
4 | New | 0.56% | |
5 | Patients | 0.47% | |
6 | Medicina | 0.43% | |
7 | COVID-19 | 0.41% | |
8 | Risk | 0.39% | |
9 | Disease | 0.38% | |
10 | COVID | 0.35% | |
11 | Salud | 0.34% | |
12 | Case | 0.34% | |
13 | News | 0.33% | |
14 | May | 0.3% | |
15 | Report | 0.29% | |
16 | Covid | 0.28% | |
17 | Dengue | 0.25% | |
18 | Heart | 0.25% | |
19 | Brain | 0.24% | |
20 | Hospital | 0.23% | |
21 | AI | 0.22% | |
22 | Research | 0.21% | |
23 | BMC | 0.2% | |
24 | HIV | 0.2% | |
25 | Treatment | 0.19% | |
26 | Abril | 0.19% | |
27 | CDC | 0.19% | |
28 | Vaccine | 0.19% | |
29 | Horoscopo | 0.18% | |
30 | Prostate | 0.18% | |
31 | Patient | 0.17% | |
32 | Linked | 0.16% | |
33 | April | 0.16% | |
34 | County | 0.16% | |
35 | World | 0.16% | |
36 | Breast | 0.15% | |
37 | Dia | 0.15% | |
38 | Care | 0.15% | |
39 | UK | 0.15% | |
40 | Parkinsons | 0.15% | |
41 | Saude | 0.14% | |
42 | Early | 0.14% | |
43 | US | 0.14% | |
44 | Day | 0.14% | |
45 | Acute | 0.14% | |
46 | Rare | 0.14% | |
47 | Australia | 0.14% | |
48 | Use | 0.14% | |
49 | Parkinson | 0.14% | |
50 | Human | 0.13% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
Rand Paul suggests Fauci covered up COVID researcher's loss of funding in 2020
KEYE TV CBS Austin
2024-04-19 03:01:17
Journal
2024-04-19 02:59:06
Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine
MarketWatch
2024-04-18 23:23:00
Long COVID patients show immunological improvement two years after infection
Medical Xpress
2024-04-18 22:44:04
How to Use Naloxone Nasal Spray | Covid-19 | news-journal.com - Longview News
Journal
2024-04-18 21:29:54
How Scripts for Case Investigation and Contact Tracing Evolved During the COVID-19 Pandemic
JPHMP Direct
2024-04-18 21:10:31
How the US failed people in prisons during Covid: ‘Really important to learn from what happened’
Coronavirus | The Guardian
2024-04-18 19:00:28
A one-shot vaccine for COVID, flu and future viruses? Researchers say it's coming
Salon
2024-04-18 18:30:00
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial
Nature.com
2024-04-18 18:20:11
COVID-19 caused drop of 24.6M TEU in container market growth, BIMCO says
WorldCargo News
2024-04-18 17:15:23
Clinical features and risk factors in COVID-19 infections | IDR
Dove Medical Press
2024-04-18 14:32:01
Global disease burden study highlights COVID-19 impact and health inequities - News
Medical.Net
2024-04-18 11:35:00
Interstitial Lung Disease With Respiratory Failure After COVID-19 mRNA Vaccination
Cureus
2024-04-18 09:29:17